261 related articles for article (PubMed ID: 26908052)
1. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.
Nilsson G; Kannius-Janson M
BMC Cancer; 2016 Feb; 16():142. PubMed ID: 26908052
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1.
Nilsson J; Helou K; Kovács A; Bendahl PO; Bjursell G; Fernö M; Carlsson P; Kannius-Janson M
Cancer Res; 2010 Mar; 70(5):2020-9. PubMed ID: 20145151
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
6. FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1.
Wang S; Yan S; Zhu S; Zhao Y; Yan J; Xiao Z; Bi J; Qiu J; Zhang D; Hong Z; Zhang L; Huang C; Li T; Liang L; Liao W; Jiao H; Ding Y; Ye Y
Neoplasia; 2018 Oct; 20(10):996-1007. PubMed ID: 30189360
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.
Fulford L; Milewski D; Ustiyan V; Ravishankar N; Cai Y; Le T; Masineni S; Kasper S; Aronow B; Kalinichenko VV; Kalin TV
Sci Signal; 2016 May; 9(427):ra48. PubMed ID: 27165781
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box C1 promotes metastasis and invasion of non-small cell lung cancer by binding directly to the lysyl oxidase promoter.
Gong R; Lin W; Gao A; Liu Y; Li J; Sun M; Chen X; Han S; Men C; Sun Y; Liu J
Cancer Sci; 2019 Dec; 110(12):3663-3676. PubMed ID: 31597217
[TBL] [Abstract][Full Text] [Related]
10. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Lysyl Oxidase Expression in Lesions and Endometrium of Women With Endometriosis.
Ruiz LA; Báez-Vega PM; Ruiz A; Peterse DP; Monteiro JB; Bracero N; Beauchamp P; Fazleabas AT; Flores I
Reprod Sci; 2015 Dec; 22(12):1496-508. PubMed ID: 25963914
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
14. Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.
Hellinger JW; Schömel F; Buse JV; Lenz C; Bauerschmitz G; Emons G; Gründker C
Sci Rep; 2020 Oct; 10(1):17889. PubMed ID: 33087801
[TBL] [Abstract][Full Text] [Related]
15. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
16. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness.
Tamura M; Sasaki Y; Koyama R; Takeda K; Idogawa M; Tokino T
Oncogene; 2014 Oct; 33(40):4837-46. PubMed ID: 24186199
[TBL] [Abstract][Full Text] [Related]
17. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
[TBL] [Abstract][Full Text] [Related]
18. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion.
Santhanam AN; Baker AR; Hegamyer G; Kirschmann DA; Colburn NH
Oncogene; 2010 Jul; 29(27):3921-32. PubMed ID: 20498644
[TBL] [Abstract][Full Text] [Related]
19. FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition.
Chu TL; Zhao HM; Li Y; Chen AX; Sun X; Ge J
Biochem Biophys Res Commun; 2014 Apr; 446(2):580-4. PubMed ID: 24632201
[TBL] [Abstract][Full Text] [Related]
20. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]